Request for Covid-19 Impact Assessment of this Report
The United States Personalized Cancer Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Personalized Cancer Vaccines market, reaching US$ million by the year 2028. As for the Europe Personalized Cancer Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Personalized Cancer Vaccines players cover Advaxis Inc, Personalis, Hoffmann-La Roche Ltd, and BioNtech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Personalized Cancer Vaccines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Others
By Mechanism of Action Type
Tumor-associated antigens (TAAs)
Tumor-specific antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Homecare
Specialty Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personalized Cancer Vaccines Market Size 2017-2028
2.1.2 Personalized Cancer Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Personalized Cancer Vaccines Segment by Type
2.2.1 Lung Cancer
2.2.2 Breast Cancer
2.2.3 Colorectal Cancer
2.2.4 Leukemia
2.2.5 Prostate Cancer
2.2.6 Cervical Cancer
2.2.7 Glioblastoma
2.2.8 Others
2.3 Personalized Cancer Vaccines Market Size by Type
2.3.1 Personalized Cancer Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)
2.4 Personalized Cancer Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Homecare
2.4.3 Specialty Clinics
2.4.4 Others
2.5 Personalized Cancer Vaccines Market Size by Application
2.5.1 Personalized Cancer Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)
3 Personalized Cancer Vaccines Market Size by Player
3.1 Personalized Cancer Vaccines Market Size Market Share by Players
3.1.1 Global Personalized Cancer Vaccines Revenue by Players (2020-2022)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2020-2022)
3.2 Global Personalized Cancer Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Personalized Cancer Vaccines by Regions
4.1 Personalized Cancer Vaccines Market Size by Regions (2017-2022)
4.2 Americas Personalized Cancer Vaccines Market Size Growth (2017-2022)
4.3 APAC Personalized Cancer Vaccines Market Size Growth (2017-2022)
4.4 Europe Personalized Cancer Vaccines Market Size Growth (2017-2022)
4.5 Middle East & Africa Personalized Cancer Vaccines Market Size Growth (2017-2022)
5 Americas
5.1 Americas Personalized Cancer Vaccines Market Size by Country (2017-2022)
5.2 Americas Personalized Cancer Vaccines Market Size by Type (2017-2022)
5.3 Americas Personalized Cancer Vaccines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Cancer Vaccines Market Size by Region (2017-2022)
6.2 APAC Personalized Cancer Vaccines Market Size by Type (2017-2022)
6.3 APAC Personalized Cancer Vaccines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Personalized Cancer Vaccines by Country (2017-2022)
7.2 Europe Personalized Cancer Vaccines Market Size by Type (2017-2022)
7.3 Europe Personalized Cancer Vaccines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Personalized Cancer Vaccines by Region (2017-2022)
8.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2017-2022)
8.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Personalized Cancer Vaccines Market Forecast
10.1 Global Personalized Cancer Vaccines Forecast by Regions (2023-2028)
10.1.1 Global Personalized Cancer Vaccines Forecast by Regions (2023-2028)
10.1.2 Americas Personalized Cancer Vaccines Forecast
10.1.3 APAC Personalized Cancer Vaccines Forecast
10.1.4 Europe Personalized Cancer Vaccines Forecast
10.1.5 Middle East & Africa Personalized Cancer Vaccines Forecast
10.2 Americas Personalized Cancer Vaccines Forecast by Country (2023-2028)
10.2.1 United States Personalized Cancer Vaccines Market Forecast
10.2.2 Canada Personalized Cancer Vaccines Market Forecast
10.2.3 Mexico Personalized Cancer Vaccines Market Forecast
10.2.4 Brazil Personalized Cancer Vaccines Market Forecast
10.3 APAC Personalized Cancer Vaccines Forecast by Region (2023-2028)
10.3.1 China Personalized Cancer Vaccines Market Forecast
10.3.2 Japan Personalized Cancer Vaccines Market Forecast
10.3.3 Korea Personalized Cancer Vaccines Market Forecast
10.3.4 Southeast Asia Personalized Cancer Vaccines Market Forecast
10.3.5 India Personalized Cancer Vaccines Market Forecast
10.3.6 Australia Personalized Cancer Vaccines Market Forecast
10.4 Europe Personalized Cancer Vaccines Forecast by Country (2023-2028)
10.4.1 Germany Personalized Cancer Vaccines Market Forecast
10.4.2 France Personalized Cancer Vaccines Market Forecast
10.4.3 UK Personalized Cancer Vaccines Market Forecast
10.4.4 Italy Personalized Cancer Vaccines Market Forecast
10.4.5 Russia Personalized Cancer Vaccines Market Forecast
10.5 Middle East & Africa Personalized Cancer Vaccines Forecast by Region (2023-2028)
10.5.1 Egypt Personalized Cancer Vaccines Market Forecast
10.5.2 South Africa Personalized Cancer Vaccines Market Forecast
10.5.3 Israel Personalized Cancer Vaccines Market Forecast
10.5.4 Turkey Personalized Cancer Vaccines Market Forecast
10.5.5 GCC Countries Personalized Cancer Vaccines Market Forecast
10.6 Global Personalized Cancer Vaccines Forecast by Type (2023-2028)
10.7 Global Personalized Cancer Vaccines Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Information
11.1.2 Advaxis Inc Personalized Cancer Vaccines Product Offered
11.1.3 Advaxis Inc Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Advaxis Inc Main Business Overview
11.1.5 Advaxis Inc Latest Developments
11.2 Personalis
11.2.1 Personalis Company Information
11.2.2 Personalis Personalized Cancer Vaccines Product Offered
11.2.3 Personalis Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Personalis Main Business Overview
11.2.5 Personalis Latest Developments
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Information
11.3.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Offered
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hoffmann-La Roche Ltd Main Business Overview
11.3.5 Hoffmann-La Roche Ltd Latest Developments
11.4 BioNtech
11.4.1 BioNtech Company Information
11.4.2 BioNtech Personalized Cancer Vaccines Product Offered
11.4.3 BioNtech Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BioNtech Main Business Overview
11.4.5 BioNtech Latest Developments
11.5 Celldex
11.5.1 Celldex Company Information
11.5.2 Celldex Personalized Cancer Vaccines Product Offered
11.5.3 Celldex Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Celldex Main Business Overview
11.5.5 Celldex Latest Developments
11.6 CureVac AG
11.6.1 CureVac AG Company Information
11.6.2 CureVac AG Personalized Cancer Vaccines Product Offered
11.6.3 CureVac AG Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 CureVac AG Main Business Overview
11.6.5 CureVac AG Latest Developments
11.7 Genetech
11.7.1 Genetech Company Information
11.7.2 Genetech Personalized Cancer Vaccines Product Offered
11.7.3 Genetech Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genetech Main Business Overview
11.7.5 Genetech Latest Developments
11.8 Genocea
11.8.1 Genocea Company Information
11.8.2 Genocea Personalized Cancer Vaccines Product Offered
11.8.3 Genocea Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Genocea Main Business Overview
11.8.5 Genocea Latest Developments
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Information
11.9.2 Gritstone Oncology Personalized Cancer Vaccines Product Offered
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Gritstone Oncology Main Business Overview
11.9.5 Gritstone Oncology Latest Developments
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Information
11.10.2 ISA Pharmaceuticals Personalized Cancer Vaccines Product Offered
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 ISA Pharmaceuticals Main Business Overview
11.10.5 ISA Pharmaceuticals Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Personalized Cancer Vaccines Product Offered
11.11.3 Merck Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Information
11.12.2 Moderna Therapeutics Personalized Cancer Vaccines Product Offered
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Moderna Therapeutics Main Business Overview
11.12.5 Moderna Therapeutics Latest Developments
12 Research Findings and Conclusion
Table 1. Personalized Cancer Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Lung Cancer
Table 3. Major Players of Breast Cancer
Table 4. Major Players of Colorectal Cancer
Table 5. Major Players of Leukemia
Table 6. Major Players of Prostate Cancer
Table 7. Major Players of Cervical Cancer
Table 8. Major Players of Glioblastoma
Table 9. Major Players of Others
Table 10. Personalized Cancer Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 12. Global Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)
Table 13. Personalized Cancer Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 14. Global Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 15. Global Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)
Table 16. Global Personalized Cancer Vaccines Revenue by Players (2020-2022) & ($ Millions)
Table 17. Global Personalized Cancer Vaccines Revenue Market Share by Player (2020-2022)
Table 18. Personalized Cancer Vaccines Key Players Head office and Products Offered
Table 19. Personalized Cancer Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Personalized Cancer Vaccines Market Size by Regions 2017-2022 & ($ Millions)
Table 23. Global Personalized Cancer Vaccines Market Size Market Share by Regions (2017-2022)
Table 24. Americas Personalized Cancer Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 25. Americas Personalized Cancer Vaccines Market Size Market Share by Country (2017-2022)
Table 26. Americas Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 27. Americas Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)
Table 28. Americas Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 29. Americas Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)
Table 30. APAC Personalized Cancer Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 31. APAC Personalized Cancer Vaccines Market Size Market Share by Region (2017-2022)
Table 32. APAC Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 33. APAC Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)
Table 34. APAC Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 35. APAC Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)
Table 36. Europe Personalized Cancer Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 37. Europe Personalized Cancer Vaccines Market Size Market Share by Country (2017-2022)
Table 38. Europe Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 39. Europe Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)
Table 40. Europe Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 41. Europe Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)
Table 42. Middle East & Africa Personalized Cancer Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Region (2017-2022)
Table 44. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)
Table 46. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)
Table 48. Key Market Drivers & Growth Opportunities of Personalized Cancer Vaccines
Table 49. Key Market Challenges & Risks of Personalized Cancer Vaccines
Table 50. Key Industry Trends of Personalized Cancer Vaccines
Table 51. Global Personalized Cancer Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 52. Global Personalized Cancer Vaccines Market Size Market Share Forecast by Regions (2023-2028)
Table 53. Global Personalized Cancer Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 54. Global Personalized Cancer Vaccines Market Size Market Share Forecast by Type (2023-2028)
Table 55. Global Personalized Cancer Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 56. Global Personalized Cancer Vaccines Market Size Market Share Forecast by Application (2023-2028)
Table 57. Advaxis Inc Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 58. Advaxis Inc Personalized Cancer Vaccines Product Offered
Table 59. Advaxis Inc Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Advaxis Inc Main Business
Table 61. Advaxis Inc Latest Developments
Table 62. Personalis Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 63. Personalis Personalized Cancer Vaccines Product Offered
Table 64. Personalis Main Business
Table 65. Personalis Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Personalis Latest Developments
Table 67. Hoffmann-La Roche Ltd Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 68. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Offered
Table 69. Hoffmann-La Roche Ltd Main Business
Table 70. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Hoffmann-La Roche Ltd Latest Developments
Table 72. BioNtech Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 73. BioNtech Personalized Cancer Vaccines Product Offered
Table 74. BioNtech Main Business
Table 75. BioNtech Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. BioNtech Latest Developments
Table 77. Celldex Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 78. Celldex Personalized Cancer Vaccines Product Offered
Table 79. Celldex Main Business
Table 80. Celldex Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Celldex Latest Developments
Table 82. CureVac AG Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 83. CureVac AG Personalized Cancer Vaccines Product Offered
Table 84. CureVac AG Main Business
Table 85. CureVac AG Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. CureVac AG Latest Developments
Table 87. Genetech Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 88. Genetech Personalized Cancer Vaccines Product Offered
Table 89. Genetech Main Business
Table 90. Genetech Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Genetech Latest Developments
Table 92. Genocea Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 93. Genocea Personalized Cancer Vaccines Product Offered
Table 94. Genocea Main Business
Table 95. Genocea Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Genocea Latest Developments
Table 97. Gritstone Oncology Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 98. Gritstone Oncology Personalized Cancer Vaccines Product Offered
Table 99. Gritstone Oncology Main Business
Table 100. Gritstone Oncology Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Gritstone Oncology Latest Developments
Table 102. ISA Pharmaceuticals Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 103. ISA Pharmaceuticals Personalized Cancer Vaccines Product Offered
Table 104. ISA Pharmaceuticals Main Business
Table 105. ISA Pharmaceuticals Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. ISA Pharmaceuticals Latest Developments
Table 107. Merck Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 108. Merck Personalized Cancer Vaccines Product Offered
Table 109. Merck Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Moderna Therapeutics Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors
Table 113. Moderna Therapeutics Personalized Cancer Vaccines Product Offered
Table 114. Moderna Therapeutics Main Business
Table 115. Moderna Therapeutics Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Moderna Therapeutics Latest Developments
List of Figures
Figure 1. Personalized Cancer Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Cancer Vaccines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Personalized Cancer Vaccines Market Size Market Share by Type in 2021
Figure 7. Personalized Cancer Vaccines in Hospitals
Figure 8. Global Personalized Cancer Vaccines Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Personalized Cancer Vaccines in Homecare
Figure 10. Global Personalized Cancer Vaccines Market: Homecare (2017-2022) & ($ Millions)
Figure 11. Personalized Cancer Vaccines in Specialty Clinics
Figure 12. Global Personalized Cancer Vaccines Market: Specialty Clinics (2017-2022) & ($ Millions)
Figure 13. Personalized Cancer Vaccines in Others
Figure 14. Global Personalized Cancer Vaccines Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Personalized Cancer Vaccines Market Size Market Share by Application in 2021
Figure 16. Global Personalized Cancer Vaccines Revenue Market Share by Player in 2021
Figure 17. Global Personalized Cancer Vaccines Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)
Figure 19. APAC Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)
Figure 20. Europe Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)
Figure 22. Americas Personalized Cancer Vaccines Value Market Share by Country in 2021
Figure 23. Americas Personalized Cancer Vaccines Consumption Market Share by Type in 2021
Figure 24. Americas Personalized Cancer Vaccines Market Size Market Share by Application in 2021
Figure 25. United States Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Personalized Cancer Vaccines Market Size Market Share by Region in 2021
Figure 30. APAC Personalized Cancer Vaccines Market Size Market Share by Application in 2021
Figure 31. China Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Personalized Cancer Vaccines Market Size Market Share by Country in 2021
Figure 38. Europe Personalized Cancer Vaccines Market Size Market Share by Type in 2021
Figure 39. Europe Personalized Cancer Vaccines Market Size Market Share by Application in 2021
Figure 40. Germany Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Application in 2021
Figure 48. Egypt Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 54. APAC Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 55. Europe Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 57. United States Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 58. Canada Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 61. China Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 62. Japan Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 63. Korea Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 65. India Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 66. Australia Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 67. Germany Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 68. France Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 69. UK Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 70. Italy Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 71. Russia Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 72. Spain Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 75. Israel Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...